Welcome to the third issue of Everyday Urology – Oncology Insights of 2020, published by Digital Science Press. This issue focuses on advances in the management of non-muscle-invasive bladder cancer and upper tract urothelial carcinoma; it also spotlights GU cancer care advancements from 2020 virtual global meetings.

This issue’s cover story is written by Patrick J. Hensley, MD, Urological Oncology Fellow, and world-renowned urologist, Ashish M. Kamat from the University of Texas MD Anderson Cancer Center, Houston, Texas, entitled: “Overcoming Diagnostic and Therapeutic Challenges in Non-muscle Invasive Bladder Cancer (NMIBC)”. In 2020, approximately 81,000 cases of urothelial carcinoma of the bladder will be diagnosed in the United States, with nearly 18,000 associated deaths.¹ In their review article, Drs. Kamat and Hensley discuss current challenges in NMIBC, emerging diagnostic approaches, and advances in both intravesical and systemic therapy.

Sam S. Chang, MD, MBA, provides a concise and well-balanced update on low-grade upper tract urothelial carcinoma in the expert perspective article. Upper tract urothelial carcinomas (UTUCs) are a heterogeneous group of malignancies arising from the urothelium within the renal pelvis or upper ureter.

X